Adagio Studying its Monoclonal Antibody for Prevention and Treatment of COVID-19

Retrieved on: 2021-06-08 11:03:45

Tags for this article:

Click the tags to see associated articles and topics

Adagio Studying its Monoclonal Antibody for Prevention and Treatment of COVID-19. View article details on hiswai:

Excerpt

The company's investigational therapy, ADG20, is a monoclonal antibody developed for both the treatment and prevention of COVID-19. ADG20 was ...

Article found on: www.contagionlive.com